RUSSELL HORNING: Open Payments
NPI 1669526158 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$32,336 in 148 payments from 16 companies in 2025. Trend: 2023 $45,022 · 2024 $42,408 · 2025 $32,336
Speaker / faculty: $25,870Travel & lodging: $3,244Food & beverage: $3,223
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 40 | $29,256 |
| Otsuka America Pharmaceutical, Inc. | 19 | $1,242 |
| Braeburn Inc. | 7 | $292 |
| ABBVIE INC. | 13 | $274 |
| Corium, LLC | 10 | $261 |
| E.R. Squibb & Sons, L.L.C. | 7 | $247 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $207 |
| Lundbeck LLC | 16 | $178 |
| Teva Pharmaceuticals USA, Inc. | 1 | $116 |
| Axsome Therapeutics, Inc. | 4 | $73 |
Products named: SPRAVATO, REXULTI, BRIXADI, VRAYLAR, Azstarys, COBENFY, CAPLYTA, AUSTEDO XR.
Industry payments across AZ — which companies pay providers there.
